MODIFICATION OF THE MUTAGENICITY AND TERATOGENICITY OF CYCLOPHOSPHAMIDE IN RATS WITH INDUCERS OF THE CYTOCHROMES-P-450

被引：37

作者：

HALES, BF

机构：

来源：

TERATOLOGY | 1981年 / 24卷 / 01期

关键词：

D O I：

10.1002/tera.1420240102

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：1 / 11

页数：11

共 36 条

[1] METHODS FOR DETECTING CARCINOGENS AND MUTAGENS WITH SALMONELLA-MAMMALIAN-MICROSOME MUTAGENICITY TEST [J].

AMES, BN ;

MCCANN, J ;

YAMASAKI, E .

MUTATION RESEARCH, 1975, 31 (06) :347-363

[2]

ASHBY R, 1976, CANCER TREAT REP, V60, P477

[3]

CONNEY AH, 1967, PHARMACOL REV, V19, P317

[4] SOME STUDIES OF ACTIVE INTERMEDIATES FORMED IN MICROSOMAL METABOLISM OF CYCLOPHOSPHAMIDE AND ISOPHOSPHAMIDE [J].

CONNORS, TA ;

COX, PJ ;

FARMER, PB ;

FOSTER, AB ;

JARMAN, M .

BIOCHEMICAL PHARMACOLOGY, 1974, 23 (01) :115-129

[5]

DEAN ME, 1975, DRUG METAB DISPOS, V3, P325

[6] TERATOGENIC BIOACTIVATION OF CYCLOPHOSPHAMIDE INVITRO [J].

FANTEL, AG ;

GREENAWAY, JC ;

JUCHAU, MR ;

SHEPARD, TH .

LIFE SCIENCES, 1979, 25 (01) :67-72

[7] ORIGIN OF DELAYED DEVELOPMENT OF DRUG METABOLISM IN NEWBORN RAT [J].

FEUER, G ;

LISCIO, A .

NATURE, 1969, 223 (5201) :68-&

[8]

FOLEY GE, 1961, CANCER RES, V21, P57

[9]

GABLER WL, 1970, ARCH INT PHARMACOD T, V184, P45

[10]

GIBSON JE, 1971, J PHARMACOL EXP THER, V177, P256

← 1 2 3 4 →